News & Public Events

Mangum New CEO of Paidion Research, Inc.

(RESEARCH TRIANGLE PARK, NC) Barry Mangum, PharmD, FCP has been named CEO of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered on Leigh Farm Road in Durham, the company provides its drug and device development partners comprehensive global services including pharmacometrics, innovative regulatory strategies and efficient, effective global trial execution.

Responsible for partnering with clients to implement clinical trials for all phases of pediatric drug development, Dr. Mangum brings decades of pediatric clinical research expertise to the job. His extensive academic experience includes serving as faculty and researcher in pediatrics and clinical pharmacology at Duke's and UNC's medical schools. His corporate experience includes stints as Director of Neonatal/Pediatric Pharmacotherapy for Wake AHEC (Area Health Education Center) and Senior Director of Pediatric Clinical Development Services at Quintiles. “Children deserve more than limited data on medicines that are being used to treat their diseases,” Dr. Mangum said. “Paidion is an organization that will energize the research community to contribute in a meaningful way to the understanding of new therapies for our next generation.”

Paidion Research, Inc. is a clinical research organization (CRO) focused solely on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered in Durham, NC, they combine pediatric clinical pharmacology expertise with innovative pediatric regulatory strategies and trial methodologies to provide best-in-class service to drug and device development partners in industry, government, academia and nonprofits. For more about the company, visit their recently launched website www.paidionresearch.com or email info@paidionresearch.com.